Researchers at MIT and Brigham and Women’s Hospital have developed a method of growing unlimited quantities of intestinal stem cells thus enabling them to better understand intestinal diseases and advance the development of more personalized and effective treatment options.
The ability to grow and study intestinal stem cells could lead to new treatment options for ulcerative colitis, immune diseases, cancers, food allergies, and other intestinal diseases. According to Robert Langer, a member of MIT’s Koch Institute for Cancer Research, “This opens the door to doing all kinds of things, ranging from someday engineering a new gut for patients with intestinal diseases to doing drug screening for safety and efficacy. It’s really the first time this has been done.”
To learn more about stem cells and how to insure access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.